Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Post by elmothefearlesson Aug 30, 2012 12:21pm
280 Views
Post# 20279742

Ze fundamentals

Ze fundamentals

$40 million market cap. less $25 million positive working capital = ~$15 million enterprise value

 

Last quarter we cash flowed about $5 million.

 

Pretty straight forward math here folks, we are trading at .75x forward cash flows (in other words, even if we go bust in 2014 because we don't get a new contract, if we can maintain cash flows for the next couple years, we are still looking at 63% return.. ~8 quarters before the hypothetical "bust" x $5 million / qtr = ~$40 million + $25 mln working capital today = ~$65 million, also factor in some break up value and we're worth at the absolute minimum ~$3.50 / share in two years time, I'll take a 75% return over 2 years anytime I can get it).

Bullboard Posts